DC Investments Management’s Novo Nordisk NVO Stock Holding History

DC Investments Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,920	Closed	-$277K	–	65
2020 Q4	$277K	Buy	+7,920	New	+$274K	0.69%	36
2020 Q3	–	Sell	-32,772	Closed	-$1.07M	–	221
2020 Q2	$1.07M	Buy	32,772 +708	+2%	+$22.6K	0.39%	28
2020 Q1	$965K	Sell	32,064 -7,916	-20%	-$236K	0.78%	14
2019 Q4	$1.16M	Hold	39,980	–	–	0.89%	8
2019 Q3	$1.03M	Buy	39,980 +5,428	+16%	+$137K	0.6%	10
2019 Q2	$882K	Sell	34,552 -6,698	-16%	-$166K	0.49%	16
2019 Q1	$1.08M	Hold	41,250	–	–	0.68%	15
2018 Q4	$950K	Buy	41,250 +16,522	+67%	+$367K	0.77%	13
2018 Q3	$583K	Sell	24,728 -8,244	-25%	-$201K	0.39%	71
2018 Q2	$760K	Buy	32,972 +21,514	+188%	+$511K	0.48%	22
2018 Q1	$282K	Buy	11,458 +3,320	+41%	+$87.2K	0.19%	200
2017 Q4	$218K	Buy	+8,138	New	+$207K	0.09%	276

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DC Investments Management's NVO Position: Q1 2021 in Review

DC Investments Management sold out of Novo Nordisk (NVO) in Q1 2021, closing a stake of 7,920 shares — an estimated $277K sold.

DC Investments Management first reported a position in NVO in Q4 2017 and held it in 12 quarters. The position peaked at $1.16M in Q4 2019. 707 funds tracked by Wall St. Rank hold NVO as of Q1 2021.

DC Investments Management reported no remaining Novo Nordisk position as of Q1 2021 after selling out during the quarter.
DC Investments Management sold 7,920 Novo Nordisk shares in Q1 2021, an estimated $277K.
DC Investments Management first reported a position in Novo Nordisk in Q4 2017 and held it in 12 quarters.
DC Investments Management's Novo Nordisk position peaked at $1.16M in Q4 2019.
707 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2021.

Based on DC Investments Management's 13F filing for Q1 2021, filed 14 May 2021.